{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T19:19:38Z","timestamp":1791487178974,"version":"4.3.4"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001427","name":"All India Council for Technical Education","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001427","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chemistry and Physics of Lipids"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1016\/j.chemphyslip.2020.104917","type":"journal-article","created":{"date-parts":[[2020,5,18]],"date-time":"2020-05-18T21:24:48Z","timestamp":1589837088000},"page":"104917","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":55,"special_numbering":"C","title":["Intranasal delivery of tetrabenazine nanoemulsion via olfactory region for better treatment of hyperkinetic movement associated with Huntington\u2019s disease: Pharmacokinetic and brain delivery study"],"prefix":"10.1016","volume":"230","author":[{"given":"Anmol","family":"Arora","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shobhit","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javed","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjula","family":"Baboota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.chemphyslip.2020.104917_bib0005","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1016\/j.jpsychires.2012.05.014","article-title":"Intranasal administration of nanostructured lipid carriers containing CNS acting drug: pharmacodynamic studies and estimation in blood and brain","volume":"46","author":"Alam","year":"2012","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.chemphyslip.2020.104917_bib0010","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1212\/WNL.0b013e318263c443","article-title":"Evidence-based guideline: pharmacologic treatment of chorea in Huntington disease: report of the guideline development subcommittee of the American Academy of Neurology","volume":"79","author":"Armstrong","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.chemphyslip.2020.104917_bib0015","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.carbpol.2013.08.027","article-title":"Chitosan and cyclodextrin in intranasal microemulsion for improved brain buspirone hydrochloride pharmacokinetics in rats","volume":"99","author":"Bshara","year":"2014","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.chemphyslip.2020.104917_bib0020","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/B978-0-444-63425-2.00010-6","article-title":"The role of dopamine in Huntington\u2019s disease","volume":"211","author":"Cepeda","year":"2014","journal-title":"Prog. Brain Res."},{"key":"10.1016\/j.chemphyslip.2020.104917_bib0025","doi-asserted-by":"crossref","first-page":"356","DOI":"10.2174\/1568026615666150108144655","article-title":"Opportunities and challenges for the nasal administration of nanoemulsions","volume":"15","author":"Comfort","year":"2015","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.chemphyslip.2020.104917_bib0030","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1046\/j.1471-4159.2001.00066.x","article-title":"Protection from MPTP\u2010induced neurotoxicity in differentiating mouse N2a neuroblastoma cells","volume":"76","author":"De Girolamo","year":"2001","journal-title":"J. Neurochem."},{"key":"10.1016\/j.chemphyslip.2020.104917_bib0035","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.ijpharm.2015.07.007","article-title":"Parenteral nanoemulsions as promising carriers for brain delivery of risperidone: design, characterization andin vivo pharmacokinetic evaluation","volume":"493","author":"Dordevic","year":"2015","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.chemphyslip.2020.104917_bib0040","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1089\/rej.2017.1959","article-title":"Attenuation of oxidative damage by coenzyme Q10 loaded nanoemulsion via oral route for the management of Parkinson\u2019s disease","volume":"21","author":"Gupta","year":"2018","journal-title":"Renjuvention Res."},{"key":"10.1016\/j.chemphyslip.2020.104917_bib0045","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1212\/01.wnl.0000198586.85250.13","article-title":"Tetrabenazine as antichorea therapy in Huntington disease: a randomized controlled trial","volume":"66","author":"Huntington Study Group","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.chemphyslip.2020.104917_bib0050","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.freeradbiomed.2013.05.041","article-title":"Novel self-emulsifying formulation of quercetin for improved in vivo antioxidant potential: implications for drug-induced cardiotoxicity and nephrotoxicity","volume":"65","author":"Jain","year":"2013","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.chemphyslip.2020.104917_bib0055","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1002\/mds.21161","article-title":"Short-term effects of tetrabenazine on chorea associated with Huntington\u2019s disease","volume":"22","author":"Kenney","year":"2007","journal-title":"Mov. Disord."},{"key":"10.1016\/j.chemphyslip.2020.104917_bib0060","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1002\/ana.410220318","article-title":"Elevated serotonin and reduced dopamine in subregionally divided Huntington\u2019s disease striatum","volume":"22","author":"Kish","year":"1987","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.chemphyslip.2020.104917_bib0065","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0169-409X(00)00122-8","article-title":"Nanoparticulate systems for brain delivery of drugs","volume":"47","author":"Kreuter","year":"2001","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.chemphyslip.2020.104917_bib0070","doi-asserted-by":"crossref","first-page":"435101","DOI":"10.1088\/0957-4484\/27\/43\/435101","article-title":"Design Expert\u00ae supported optimization and predictive analysis of selegiline nanoemulsion via the olfactory region with enhanced behavioural performance in Parkinson\u2019s disease","volume":"27","author":"Kumar","year":"2016","journal-title":"Nanotechnology"},{"key":"10.1016\/j.chemphyslip.2020.104917_bib0075","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1089\/rej.2017.2035","article-title":"Selegiline nanoformulation in attenuation of oxidative stress and upregulation of dopamine in the brain for the treatment of Parkinson\u2019s disease","volume":"21","author":"Kumar","year":"2018","journal-title":"Rejuvenation Res."},{"key":"10.1016\/j.chemphyslip.2020.104917_bib0080","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1615\/CritRevNeurobiol.v17.i1.20","article-title":"On the use of neuro-2a neuroblastoma cells versus intact neurons in primary culture for neurotoxicity studies","volume":"17","author":"LePage","year":"2005","journal-title":"Crit. Rev. Neurobiol."},{"key":"10.1016\/j.chemphyslip.2020.104917_bib0085","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.ijpharm.2006.08.043","article-title":"Enhancing effect of surfactants on fexofenadine.HCl transport across the human nasal epithelial cell monolayer","volume":"330","author":"Lin","year":"2007","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.chemphyslip.2020.104917_bib0090","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.molliq.2015.10.027","article-title":"Nanoemulsion as a tool for improvement of cilostazol oral bioavailability","volume":"212","author":"Mahour","year":"2015","journal-title":"J. Mol. Liq."},{"key":"10.1016\/j.chemphyslip.2020.104917_bib0095","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/0006-3223(93)90012-3","article-title":"Monoamines and their metabolites in Huntington\u2019s disease brain: evidence for decreased catechol-O-methyltransferase activity","volume":"33","author":"McGeer","year":"1993","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.chemphyslip.2020.104917_bib0100","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.parkreldis.2011.10.021","article-title":"An evidence-based approach in the treatment of Huntington\u2019s disease","volume":"18","author":"Mestre","year":"2012","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.chemphyslip.2020.104917_bib0105","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.ijpharm.2009.06.019","article-title":"Nanoparticles for direct nose-to-brain delivery of drugs","volume":"379","author":"Mistry","year":"2009","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.chemphyslip.2020.104917_bib0110","doi-asserted-by":"crossref","first-page":"e18336","DOI":"10.1371\/journal.pone.0018336","article-title":"Altered dopamine and serotonin metabolism in motorically asymptomatic R6\/2 mice","volume":"6","author":"Mochel","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.chemphyslip.2020.104917_bib0115","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.jddst.2017.05.019","article-title":"Quality by design based silymarin nanoemulsion for enhancement of oral bioavailability","volume":"40","author":"Nagi","year":"2017","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.chemphyslip.2020.104917_bib0120","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1021\/js960483y","article-title":"Mechanistic roles of neutral surfactants on concurrent polarized and passive membrane transport of a model peptide in Caco-2 cells","volume":"86","author":"Nerurkar","year":"1997","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.chemphyslip.2020.104917_bib0125","doi-asserted-by":"crossref","first-page":"025102","DOI":"10.1088\/0957-4484\/27\/2\/025102","article-title":"Intranasal delivery of paroxetine nanoemulsion via the olfactory region for the management of depression: formulation, behavioural and biochemical estimation","volume":"27","author":"Pandey","year":"2016","journal-title":"Nanotechnology"},{"key":"10.1016\/j.chemphyslip.2020.104917_bib0130","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.3109\/03639041003657295","article-title":"Cannabidiol bioavailability after nasal and transdermal application: effect of permeation enhancers","volume":"36","author":"Paudel","year":"2010","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.chemphyslip.2020.104917_bib0135","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/0014-2999(84)90562-4","article-title":"Tetrabenazine-induced depletion of brain monoamines: characterization and interaction with selected antidepressants","volume":"102","author":"Pettibone","year":"1984","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.chemphyslip.2020.104917_bib0140","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1345\/aph.1M582","article-title":"Role of tetrabenazine for Huntington\u2019s disease\u2013associated chorea","volume":"44","author":"Poon","year":"2010","journal-title":"Ann. Pharmacother."},{"key":"10.1016\/j.chemphyslip.2020.104917_bib0145","doi-asserted-by":"crossref","first-page":"166","DOI":"10.18632\/aging.100131","article-title":"Interpretation and applicability of microRNA data to the context of Alzheimers and age-related diseases","volume":"2","author":"Provost","year":"2010","journal-title":"Aging"},{"key":"10.1016\/j.chemphyslip.2020.104917_bib0150","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1046\/j.1460-9568.2000.00078.x","article-title":"Polysorbate-80 coating enhances uptake of polybutylcyanoacrylate (PBCA)-nanoparticles by human and bovine primary brain capillary endothelial cells","volume":"12","author":"Ramge","year":"2000","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.chemphyslip.2020.104917_bib0155","doi-asserted-by":"crossref","first-page":"e0135614","DOI":"10.1371\/journal.pone.0135614","article-title":"\u03b2-Hydroxy-\u03b2-Methylbutyrate (HMB) promotes neurite outgrowth in Neuro2a cells","volume":"10","author":"Salto","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.chemphyslip.2020.104917_bib0160","first-page":"1","article-title":"Optimised nanoformulation of bromocriptine for direct nose-to-brain delivery: biodistribution, pharmacokinetic and dopamine estimation by ultra-HPLC\/mass spectrometry method","volume":"11","author":"Shadab","year":"2014","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.chemphyslip.2020.104917_bib0165","doi-asserted-by":"crossref","first-page":"918","DOI":"10.3109\/10717544.2013.878857","article-title":"Nose to brain microemulsion-based drug delivery system of rivastigmine: formulation and ex-vivo characterization","volume":"22","author":"Shah","year":"2014","journal-title":"Drug Deliv."},{"key":"10.1016\/j.chemphyslip.2020.104917_bib0170","doi-asserted-by":"crossref","first-page":"541","DOI":"10.3109\/10717544.2014.893382","article-title":"Effect of high pressure homogenization on formulation of TPGS loaded nanoemulsion of rutin\u2014pharmacodynamic and antioxidant studies","volume":"22","author":"Sharma","year":"2015","journal-title":"Drug Deliv."},{"key":"10.1016\/j.chemphyslip.2020.104917_bib0175","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.jpsychires.2018.01.015","article-title":"Duloxetine loaded-microemulsion system to improve behavioral activities by upregulating serotonin and norepinephrine in brain for the treatment of depression","volume":"99","author":"Sindhu","year":"2018","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.chemphyslip.2020.104917_bib0180","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1039\/C5RA19793G","article-title":"Intranasal delivery of asenapine loaded nanostructured lipid carriers: formulation, characterization, pharmacokinetic and behavioural assessment","volume":"6","author":"Singh","year":"2016","journal-title":"RSC Adv."},{"key":"10.1016\/j.chemphyslip.2020.104917_bib0185","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1093\/brain\/103.1.179","article-title":"Neurochemical alterations in Huntington\u2019s chorea: a study of post-mortem brain tissue","volume":"103","author":"Spokes","year":"1980","journal-title":"Brain"},{"key":"10.1016\/j.chemphyslip.2020.104917_bib0190","doi-asserted-by":"crossref","first-page":"233e43","DOI":"10.1016\/0006-8993(95)00674-F","article-title":"Regional distribution of monoamine vesicular uptake sites in the mesencephalon of control subjects and patients with Parkinson\u2019s disease: a postmortem study using tritiated tetrabenazine","volume":"692","author":"Thibaut","year":"1995","journal-title":"Brain Res."},{"key":"10.1016\/j.chemphyslip.2020.104917_bib0195","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.neuroscience.2004.05.029","article-title":"Delivery of insulin-like growth factor-I to the rat brain and spinal cord along olfactory and trigeminal pathways following intranasal administration","volume":"127","author":"Thorne","year":"2004","journal-title":"Neuroscience"},{"key":"10.1016\/j.chemphyslip.2020.104917_bib0200","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.ijpharm.2015.10.033","article-title":"Formulation design and in vitro physicochemical characterization of surface modified self-nanoemulsifying formulations (SNEFs) of gentamicin","volume":"497","author":"Umeyora","year":"2016","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.chemphyslip.2020.104917_bib0205","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1080\/10611860500246217","article-title":"Intranasal mucoadhesive microemulsions of zolmitriptan: preliminary studies on brain-targeting","volume":"13","author":"Vyas","year":"2005","journal-title":"J. Drug Target."},{"key":"10.1016\/j.chemphyslip.2020.104917_bib0210","doi-asserted-by":"crossref","first-page":"E12","DOI":"10.1208\/ps020212","article-title":"Light scattering investigations on dilute non-ionic oil-in-water microemulsions","volume":"2","author":"Warisnoicharoen","year":"2000","journal-title":"AAPS Pharm. Sci."},{"key":"10.1016\/j.chemphyslip.2020.104917_bib0215","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.rinphs.2014.09.001","article-title":"Effect of the excipient concentration on the pharmacokinetics of PM181104, a novel antimicrobial thiazolyl cyclic peptide antibiotic, following intravenous administration to mice","volume":"4","author":"Yemparala","year":"2014","journal-title":"Results Pharma Sci."},{"key":"10.1016\/j.chemphyslip.2020.104917_bib0220","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1111\/jocd.12369","article-title":"In vitro evaluation of chitosan-coated liposome containing both coenzyme Q10 and alpha-lipoic acid: cytotoxicity, antioxidant activity, and antimicrobial activity","volume":"17","author":"Zhao","year":"2018","journal-title":"J. Cosmet. Dermatol."}],"container-title":["Chemistry and Physics of Lipids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009308420300487?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009308420300487?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T14:32:09Z","timestamp":1757860329000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009308420300487"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":44,"alternative-id":["S0009308420300487"],"URL":"https:\/\/doi.org\/10.1016\/j.chemphyslip.2020.104917","relation":{},"ISSN":["0009-3084"],"issn-type":[{"value":"0009-3084","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intranasal delivery of tetrabenazine nanoemulsion via olfactory region for better treatment of hyperkinetic movement associated with Huntington\u2019s disease: Pharmacokinetic and brain delivery study","name":"articletitle","label":"Article Title"},{"value":"Chemistry and Physics of Lipids","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.chemphyslip.2020.104917","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"104917"}}